NEW YORK, May 27, 2016 /PRNewswire/ --
At present, the Biotech sphere is in a volatile state, but
investors playing in this space know that volatility is what makes
this industry interesting to consider. Here are this morning's
featured companies on ActiveWallSt.com: Synta Pharmaceuticals Corp.
(NASDAQ: SNTA), CTI BioPharma Corp. (NASDAQ: CTIC), Lpath Inc.
(NASDAQ: LPTN), and Heat Biologics Inc. (NASDAQ: HTBX). Sign up now
and gain access to the technical alerts for these stocks at:
http://www.activewallst.com/register/
Let us now see the performances of these equities after the
closing bell on Thursday, May 26,
2016:
Synta Pharmaceuticals Corp.'s stock finished yesterday's trading
session at $0.36, which was a
correction of 5.11%. A total volume of 319,230 shares was traded.
The Company focuses on the research, development, and
commercialization of novel oncology medicines for cancer patients.
The Company's shares have advanced 56.78% over the previous three
months and 3.03% since the start of this year. The stock is trading
above its 50-day moving average by 10.21%. Additionally, shares of
Synta Pharmaceuticals have a Relative Strength Index (RSI) of
48.50. Sign up and get the alert on SNTA at:
http://www.activewallst.com/register/
On Thursday, shares in biopharma Company, CTI BioPharma Corp.,
ended the session at $0.45, which was
a slight correction of 0.31% from their previous close. The Company
engages in the acquisition, development, and commercialization of
novel targeted therapies for blood-related cancers in the U.S. and
internationally. The stock recorded a total volume of 341,690
shares traded. The Company's shares are trading 9.02% below their
50-day moving average. The stock has an RSI of 44.81. The
complimentary alert on CTIC can be activated at:
http://www.activewallst.com/register/
California-based biotechnology
Company, Lpath Inc.'s stock saw a correction of 4.06%, closing the
session at $0.17 with a total volume
of 274,299 shares traded. The Company's shares are trading 16.54%
below their 200-day moving average. The stock has an RSI of 43.46.
Register for free on ActiveWallSt.com and access the latest
strategies on LPTN at:
http://www.activewallst.com/register/
On Thursday, shares in Heat Biologics Inc. recorded a trading
volume of 286,134 shares, and ended the day 5.83% higher at
$0.63. The Company focuses on the
development and commercialization of novel allogeneic off-the-shelf
cellular therapeutic vaccines for a range of cancers and infectious
diseases in the U.S. The stock is trading below its 50-day moving
average by 4.14%. The Company's shares have an RSI of 55.47. The
complete trade setup on HTBX is available for free at:
http://www.activewallst.com/register/
--
Active Wall Street:
Active Wall Street (AWS) produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. AWS has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
AWS has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and
reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by AWS. AWS is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
AWS, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. AWS, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, AWS, the Author, and the Reviewer do not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither AWS nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.activewallst.com/disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly
at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA
